%0 Journal Article
%T The role of automated insulin delivery technology in diabetes.
%A Boughton CK
%A Hovorka R
%J Diabetologia
%V 0
%N 0
%D 2024 May 13
%M 38740602
%F 10.46
%R 10.1007/s00125-024-06165-w
%X The role of automated insulin delivery systems in diabetes is expanding. Hybrid closed-loop systems are being used in routine clinical practice for treating people with type 1 diabetes. Encouragingly, real-world data reflects the performance and usability observed in clinical trials. We review the commercially available hybrid closed-loop systems, their distinctive features and the associated real-world data. We also consider emerging indications for closed-loop systems, including the treatment of type 2 diabetes where variability of day-to-day insulin requirements is high, and other challenging applications for this technology. We discuss issues around access and implementation of closed-loop technology, and consider the limitations of present closed-loop systems, as well as innovative approaches that are being evaluated to improve their performance.